The Discovery of a New Generation of Tubulin Inhibitors for Metastatic Cancer
Thursday, May 25, 2023
12:00 pm - 1:00 pm
This event is a hybrid event. A Zoom link will be sent to those registered through Eventbrite.
About the Event:
Tubulin inhibitors (e.g., paclitaxel) are widely used chemotherapeutic drugs in treating various types of cancers. However, their clinical efficacy is often limited by drug efflux pumps and non-specific tissue distribution, leading to dose-limiting toxicity. We have discovered a new generation of orally bioavailable tubulin inhibitors that are promising for treating metastatic cancers.
About the Speaker:
Wei Li, Ph.D., is currently a Distinguished Professor at the University of Tennessee Health Science Center (UTHSC), the Director of the UTHSC College of Pharmacy (UTCoP) Drug Discovery Center, and the Faculty Director of the Shared Analytical Instrument Facility at UTCoP. He is also the Founder of SEAK Therapeutics LLC, a UTHSC spin-off company. Li’s research focus is small molecule drug discovery and development. He has published about 200 peer-reviewed papers, authored five book chapters and is an inventor of 13 issued U.S. patents.
Contact Info:
For more information, contact Nadine Peterson, DDI Coordinator
- Location
- Student Health Center, 4349 Martin Luther King Blvd, Health Building 2, Room 3082, Houston, Texas 77204
- Cost
- Free